397
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Managing Weight in Persons Living with Severe Mental Illness in Community Settings: A Review of Strategies Used in Community Interventions

, JD, PhD & , MPH, MD
Pages 660-668 | Published online: 08 Oct 2009

REFERENCES

  • Allison D. B., Mackell J. A., McDonnell D. D. The impact of weight gain on quality of life among persons with schizophrenia. Psychiatric Services. 2003; 54: 565–567
  • American Diabetes Association. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care 2004; 27: 596–601
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., text rev. Author. 2000
  • Aquila R. Management of weight gain in patients with schizophrenia. Journal of Clinical Psychiatry 2002; 63(suppl 4)33–36
  • Aquila R., Emanuel M. Interventions for weight gain in adults treated with novel antipsychotics. Primary Care Companion Journal of Clinical Psychiatry 2000; 2: 20–23
  • Ball M. P., Coons V. B., Buchanan R. W. A program for treating Olanzapine-related weight gain. Psychiatric Services. 2000; 52: 967–969
  • Bernard J. L. Rapid treatment of gross obesity by operant techniques. Psychological Reports. 1968; 23: 663–666
  • Birt J. Management of weight gain associated with antipsychotics. Annals of Clinical Psychiatry. 2003; 15: 49–58
  • Bradshaw T., Lovell K., Harris N. Healthy living interventions and schizophrenia: A systematic review. Journal of Advanced Nursing. 2005; 49: 634–654
  • Brown S., Chan K. A randomized controlled trial of a brief health promotion intervention in a population with serious mental illness. Journal of Mental Health. 2006; 15: 543–549
  • Catapano L., Castle D. Obesity in schizophrenia: What can be done about it?. Australasian Psychiatry 2004; 12: 23–25
  • Centorrino F., Wurtman J. J., Duca K. A., Fellman V. H., Fogarty K. V., Berry J. M., et al. Weight loss in overweight patients maintained on atypical antipsychotic agents. International Journal of Obesity. 2006; 30: 1–6
  • Covell N. H., Finnerty M. T., Essock S. M. Implications of CATIE for mental health services researchers. Psychiatric Services 2008; 29: 526–529
  • Daumit G. L., Clark J. M., Steinwachs D. M., Graham C. M., Lehman A., Ford D. E. Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. Journal of Nervous and Mental Disease. 2003; 191: 799–805
  • Daumit G. L., Goldberg R. W., Anthony C., Dickerson F., Brown C. H., Kreyenbuhl J., Wohlheiter K., Dixon L. B. Physical activity patterns in adults with severe mental illness. Journal of Nervous & Mental Disease. 2005; 193: 641–646
  • Evans S., Newton R., Higgins S. Individual dietary education reduces Olanzapine associated weight gain. Evidence Based Mental Health 2006; 9: 11
  • Farwell W. R., Stump T. E., Wang J., Tafesse E., L'Italien G., Tierney W. M. Weight gain and new onset diabetes associated with Olanzapine and Risperidone. Journal of General Internal Medicine. 2004; 19: 1200–1205
  • Faulkner G., Soundy A. A., Lloyd K. Schizophrenia and weight management: A systematic review of interventions to control weight. Acta Psychiatrica Scandinavica. 2003; 108: 324–332
  • Feeney L., Dempsey J., Moynihan F., Barry S. Changes in body mass indices of patients with schizophrenia 3 years following the introduction of a weight management programme. Irish Medical Journal. 2003; 96: 276–277
  • Ganguli R. Behavioral therapy for weight loss in patients with schizophrenia. Journal of Clinical Psychiatry 2007; 68: 19–25
  • Ganguli R., Brar J. S. (2005) Prevention of weight gain, by behavioral interventions, in patients starting novel antipsychotics. XX International Congress on Schizophrenia Research, Savannah, Georgia, April, 2–62005
  • Godin G., Shephard R. J. A simple method to assess exercise behavior in the community. Canadian of Applied Sport Sciences. 1985; 10: 141–146
  • Green A. I., Patel J. K., Goisman R. M., Allison D. B., Blackburn G. Weight gain from novel antipsychotic drugs: Need for action. General Hospital Psychiatry 2000; 22: 224–235
  • Hamer M., Stamatakis E., Steptoe A. Psychiatric hospital admissions, behavioral risk factors, and all-cause mortality: The Scottish health survey. Archives of Internal Medicine 2008; 168(22)2474–2479
  • Hester E. K., Thrower M. R. Current options in the management of Olanzapine-associated weight gain. Annals of Pharmacotherapy. 2005; 39: 302–310
  • Kalarchian M. A., Marcus M. D., Levine M. D., Haas G. L., Greeno C. G., Weissfeld L. A., et al. Behavioral treatment of obesity in patients taking antipsychotic medications. Journal of Clinical Psychiatry. 2005; 66: 1058–1063
  • Kessler R. C., Chiu W. T., Demler O., Walters E. E. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry 2005; 62: 617–627
  • Kilbourne A. M., Rofey D. L., McCarthy J. F., Post E. P., Welsh D., Blow F. C. Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disorders. 2007; 9: 443–452
  • Knox J. M. A study of weight reducing diets in psychiatric in-patients. British Journal of Psychiatry. 1980; 136: 287–289
  • Kwon J. S., Choi J.-S., Bahk W.-M., Kim C. Y., Kim C. H., Shin Y. C., et al. Weight management program for treatment-emergent weight gain in Olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. Journal of Clinical Psychiatry. 2006; 67: 547–553
  • Littrell K. H., Hilligross N. M., Kirshner C. D., Perry R. G., Johnson C. G. The effects of an educational intervention on antipsychotic-induced weight gain. Journal of Nursing Scholarship. 2003; 35: 237–241
  • Loh C., Meyer J. M., Leckband S. G. A comprehensive review of behavioral interventions for weight management in schizophrenia. Annals of Clinical Psychiatry. 2006; 18: 23–31
  • Malone M. Medications associated with weight gain. Annals of Pharmacotherapy. 2005; 39: 2046–2055
  • Menza M., Vreeland B., Minsky S., Gara M., Radler D. R., Sakowitz M. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. Journal of Clinical Psychiatry. 2004; 65: 471–477
  • Moller H. Outcomes in major depressive disorder: The evolving concept of remission and its implications for treatment. World Journal of Biological Psychiatry. 2008; 9: 102–114
  • National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. National Institutes of Health, BethesdaMaryland 1998, NIH Publication No. 98-4083
  • Nguyen C. T., Yu B., Maguire G. Update on atypicals: Preemptive tactics to reduce weight gain. Current Psychiatry Online Evidence-Based Reviews 2003; 2(3)58–62, Retrieved October 18, 2005, from http://www.Currentpsychiatry.com
  • O'Neil P. M., Currey H. S., Hirsch A. A., Malcolm R. J., Sexauer J. D., Riddle F. E., et al. Development and validation of the Eating Behavior Inventory. Journal of Behavioral Assessment. 1979; 1: 123–132
  • Paffenbarger R. S., Wing A. L., Hyde R. T. Physical activity as an index of heart attack risk in college alumni. American Journal of Epidemiology. 1978; 108: 161–175
  • Peck M. C., Scheffler R. M. An analysis of the definitions of mental illness used in state parity laws. Psychiatric Services 2002; 53(9)1089–1095
  • Peeters A., Barendregt J. J., Willekens F., Mackenbach J. P., Mamun A. A., Bonneux L. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Annals of Internal Medicine. 2003; 138: 24–32
  • Poston W. S. C., II, Foreyt J. P. Successful management of the obese patient. American Family Physician. 2000; 61: 3615–3622
  • Rege S. Antipsychotic induced weight gain in schizophrenia: Mechanisms and management. Australian and New Zealand Journal of Psychiatry 2008; 42: 369–381
  • Richardson C. R. A lifestyle physical activity program for persons with serious mental illness. Psychiatric Services 2005; 56: 354
  • Richardson C. R., Avripas S. A., Neal D. L., Marcus S. M. Increasing lifestyle physical activity in patients with depression or other serious mental illness. Journal of Psychiatric Practice. 2005; 11: 379–388
  • Richardson C. R., Faulkner G., McDevitt J., Skrinar G. S., Hutchinson D. S., Piette J. D. Integrating physical activity into mental health services for persons with serious mental illness. Psychiatric Services 2005; 56: 324–331
  • Roe L., Strong C., Whiteside C., Neil A., Mant D. Dietary intervention in primary care: Validity of the DINE method of diet assessment. Family Practice. 1994; 11: 375–381
  • Sansone R. A., Sansone L. A., Gaither G. A., Morris J. L. Patient attitudes toward weight gain with medications. General Hospital Psychiatry. 2004; 26: 487–489
  • Schretlen D., Jayaram G., Maki P., Park K., Abebe S., DiCarlo M. Demographic, clinical, and neuroncognitive correlates of everyday functional impairment in severe mental illness. Journal of Abnormal Psychology. 2000; 109: 134–138
  • Scocco P., Longo R., Caon F. Weight change in treatment with Olanzapine and a psychoeducational approach. Eating Behaviors. 2006; 7: 115–124
  • Skrinar G. S., Huxley N. A., Hutchinson D. S., Menninger E., Glew P. The role of a fitness intervention on people with serious psychiatric disabilities. Psychiatric Rehabilitation Journal. 2005; 29: 122–127
  • Stice E., Shaw H., Marti C. N. A meta-analytic review of obesity prevention programs for children and adolescents: The skinny on interventions that work. Psychological Bulletin. 2006; 132: 667–691
  • Strassnig M., Brar J. S., Ganguli R. Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophrenia Research. 2003; 62: 73–76
  • Stroup T. S., Lieberman J. A., McEvoy J. P., Swartz M. S., Davis S. M., Capuano G. A., et al. Effectiveness of Olanzapine, Quetiapine, and Risperidone in patients with chronic schizophrenia after discontinuing Perphenazine: A CATIE Study. American Journal of Psychiatry 2007; 164: 415–427
  • Torrent C., Amann B., Sanchez-Moreno J., Colom F., Reinares M., Comes M., et al. Weight gain in bipolar disorder: Pharmacological treatment as a contributing factor. Acta Psychiatrica Scandinavica. 2008; 118: 4–18
  • Umbricht D., Flury H., Bridler R. Cognitive behavioral therapy for weight gain. American Journal of Psychiatry 2001; 158: 971
  • Virk S., Schwartz T. L., Jindal S., Nihalani N., Jones N. Psychiatric medication induced obesity: An aetiologic review. Obesity Reviews. 2004; 5: 167–170
  • Ware J. E., Jr., Sherbourne C. D. The MOS 36-item Short-Form Health Survey (SF-36) I. Conceptual framework and item selection. Medical Care 1992; 30: 473–483
  • Washburn R. A., Smith K. W., Jette A. M., Janney C. A. The Physical Activity Scale for the Elderly (PASE): Development and evaluation. Journal of Clinical Epidemiology. 1993; 46: 153–162
  • Weber M., Wyne K. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophrenia Research. 2006; 83: 96–101
  • Weiden P. J., Mackell J. A., McDonnell D. D. Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Research 2004; 66: 51–57
  • Werneke U., Taylor D., Sanders T. A. B., Wessely S. Behavioural management of antipsychotic-induced weight gain: A review. Acta Psychiatrica Scandinavica 2003; 108: 252–259

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.